Satsuma Pharmaceuticals

    OverviewSuggest Edit

    Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers.

    TypePublic
    Founded2016
    HQSouth San Francisco, US
    Websitesatsumarx.com

    Latest Updates

    Employees (est.) (Sep 2019)13

    Satsuma Pharmaceuticals Office Locations

    Satsuma Pharmaceuticals has offices in South San Francisco and Durham
    South San Francisco, US (HQ)
    400 Oyster Point Blvd #221South
    Durham, US
    4819 Emperor Blvd #340
    Show all (2)

    Satsuma Pharmaceuticals Financials and Metrics

    Satsuma Pharmaceuticals Revenue

    USD

    Net income (FY, 2018)

    (7.3m)

    EBIT (FY, 2018)

    (7.5m)

    Cash (31-Dec-2018)

    5.2m
    USDFY, 2017FY, 2018

    General and administrative expense

    754.0k1.1m

    R&D expense

    4.2m6.4m

    Operating expense total

    4.9m7.5m

    EBIT

    (4.9m)(7.5m)
    USDFY, 2017FY, 2018

    Cash

    1.7m5.2m

    Prepaid Expenses

    256.0k199.0k

    Current Assets

    1.9m5.4m

    PP&E

    70.0k445.0k
    USDFY, 2017FY, 2018

    Net Income

    (5.2m)(7.3m)

    Depreciation and Amortization

    10.0k57.0k

    Accounts Payable

    363.0k(177.0k)

    Cash From Operating Activities

    (4.3m)(7.0m)
    USDY, 2018

    Debt/Equity

    -10.3 x

    Debt/Assets

    0.8 x

    Financial Leverage

    -13.2 x
    Show all financial metrics

    Satsuma Pharmaceuticals Operating Metrics

    Aug, 2019

    Drugs in Development

    37

    Patents (Foreign)

    9

    Patents (US)

    6
    Show all operating metrics

    Satsuma Pharmaceuticals Online and Social Media Presence

    Embed Graph

    Satsuma Pharmaceuticals News and Updates

    Satsuma Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock

    SOUTH SAN FRANCISCO, Calif., Sept. 12, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or the "Company") (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine, today announced...

    Satsuma Pharmaceuticals sets IPO terms to raise up to $80 million

    Satsuma Pharmaceuticals Inc. has set terms for its initial public offering, to raise up to $80 million and value the biopharmaceutical company, which is developing migraine treatments, at about $257.7 million. San Francisco-based Satsuma is offering 5 million shares in the IPO, which is expected to…

    Satsuma Pharmaceuticals Appoints Elisabeth Sandoval to Board of Directors

    SOUTH SAN FRANCISCO, Calif., May 29, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a Phase 3-stage biopharmaceutical company developing STS101, (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine, today announced that Elisabeth...

    Satsuma Pharmaceuticals Provides Corporate Update and Prepares to Advance Lead Product Candidate, STS101, Into Phase 3 Efficacy Trial for Acute Migraine

    SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company, today provided a corporate update, including recent progress with its development of STS101 for the acute treatment of...

    Satsuma Pharmaceuticals Frequently Asked Questions

    • When was Satsuma Pharmaceuticals founded?

      Satsuma Pharmaceuticals was founded in 2016.

    • How many employees does Satsuma Pharmaceuticals have?

      Satsuma Pharmaceuticals has 13 employees.

    • Who are Satsuma Pharmaceuticals competitors?

      Competitors of Satsuma Pharmaceuticals include Mylan, Generex Biotechnology and Opiant Pharmaceuticals.

    • Where is Satsuma Pharmaceuticals headquarters?

      Satsuma Pharmaceuticals headquarters is located at 400 Oyster Point Blvd #221South, South San Francisco.

    • Where are Satsuma Pharmaceuticals offices?

      Satsuma Pharmaceuticals has offices in South San Francisco and Durham.

    • How many offices does Satsuma Pharmaceuticals have?

      Satsuma Pharmaceuticals has 2 offices.